These posts are patient facing and may include quotes, photos, or other images.
Although low bone mineral density (BMD) is strongly associated with increased fracture risk, up to 50% of those who suffer […]
Based on bone densitometric measurements, weight loss induced by dietary restriction is known to be accompanied by reduced areal bone
The assessment of fracture risk often relies primarily on measuring bone mineral density, thereby accounting for only a single pathology:
Dual-energy X-ray absorptiometry (DXA) is generally a very useful tool for assessing bone mineral density (BMD) and fracture risk. However,
Indication For Use and Safety Information
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
Like with any percutaneous procedure, there is a small risk of infection. The sale, distribution, and use of the OsteoProbe are restricted to prescription use. Federal law (United States of America) restricts this device to use by, or on the order of, a physician.
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy